Skip to main content
Premium Trial:

Request an Annual Quote

Sigma-Aldrich Buys Biopharmaceutical Product Manufacturer MMB

NEW YORK (GenomeWeb News) - Sigma-Aldrich has acquired the biopharmaceutical contract manufacturer Molecular Medicine BioServices for an undisclosed amount of cash, Sigma said yesterday.
 
Sigma said it bought the Carlsbad, Calif.-based MMB to expand its SAFC Pharma business segment.
 
Sigma said MMB’s $12 million in annualized revenues will help it reach its growth goals, but will have a neutral impact on earnings in 2007.
 
MMB develops and manufactures viral products and offers DNA, RNA, and active ingredients for the production of novel vaccines and gene therapies. The company has 60 employees, a 23,700-square-foot lab and headquarters, and a 21,400-square-foot manufacturing facility.
 
Sigma said it plans to retain all of MMB's existing management and employees.
 
Sigma’s SAFC segment focuses on high-purity inorganics, cell culture products, and other services.
 
SAFC president Frank Wicks said the addition of MMB gives the company "critical capability" to produce viruses, and will complement the company's transgenic extraction and purification facility in St. Louis and a bacterial fermentation lab it is building in Israel.

The Scan

Panel Recommends Pfizer-BioNTech Vaccine for Kids

CNN reports that the US Food and Drug Administration advisory panel has voted in favor of authorizing the Pfizer-BioNTech SARS-CoV-2 vaccine for children between 5 and 11 years old.

Sharing How to Make It

Merck had granted a royalty-free license for its COVID-19 treatment to the Medicines Patent Pool, according to the New York Times.

Bring it Back In

Bloomberg reports that a genetic analysis has tied a cluster of melioidosis cases in the US to a now-recalled aromatherapy spray.

Nucleic Acids Research Papers on SomaMutDB, VThunter, SCovid Databases

In Nucleic Acids Research this week: database of somatic mutations in normal tissue, viral receptor-related expression signatures, and more.